日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study

使用 UHPLC-MS/MS 对血液、血浆和尿液中的他非诺喹和 5,6-邻醌他非诺喹进行定量分析,并应用于药代动力学研究

Geoffrey W Birrell, Karin Van Breda, Bridget Barber, Rebecca Webster, James S McCarthy, G Dennis Shanks, Michael D Edstein

Cross-sectional study of asymptomatic malaria and seroepidemiological surveillance of seven districts in Gia Lai province, Vietnam

越南嘉莱省七县无症状疟疾横断面研究及血清流行病学监测

Nguyen Ngoc San #, Nguyen Xuan Kien #, Nguyen Duc Manh, Nguyen Van Thanh, Marina Chavchich, Nguyen Thi Huong Binh, Tran Khanh Long, Kimberly A Edgel, Eduard Rovira-Vallbona, Michael D Edstein, Nicholas J Martin

Cross-sectional survey of asymptomatic malaria in Dak Nong province in the Central Highlands of Vietnam for the malaria elimination roadmap

为制定消除疟疾路线图对越南中部高地多农省无症状疟疾进行横断面调查

Huynh Hong Quang, Marina Chavchich, Nguyen Thi Minh Trinh, Nguyen Duc Manh, Michael D Edstein, Nicholas J Martin, Kimberly A Edgel

Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum

对新型强效抗疟药 JPC-3210 作用方式进行多组学表征,以对抗恶性疟原虫

Geoffrey W Birrell, Matthew P Challis, Amanda De Paoli, Dovile Anderson, Shane M Devine, Gavin D Heffernan, David P Jacobus, Michael D Edstein, Ghizal Siddiqui, Darren J Creek

Characterization of the Preclinical Pharmacology of the New 2-Aminomethylphenol, JPC-3210, for Malaria Treatment and Prevention

用于治疗和预防疟疾的新型 2-氨基甲基苯酚 JPC-3210 的临床前药理学表征

Geoffrey W Birrell #, Gavin D Heffernan #, Guy A Schiehser #, John Anderson, Arba L Ager, Pablo Morales, Donna MacKenzie, Karin van Breda, Marina Chavchich, Laura R Jacobus, G Dennis Shanks, David P Jacobus, Michael D Edstein

The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam

青蒿素-哌喹(Artequick®)与青蒿琥酯-阿莫地喹(Coarsucam™)在治疗越南中南部无并发症恶性疟原虫疟疾的疗效和耐受性

Nguyen Xuan Thanh, Trieu Nguyen Trung, Nguyen Chinh Phong, Huynh Hong Quang, Bui Dai, G Dennis Shanks, Marina Chavchich, Michael D Edstein